Kairos Pharma KAPA
NYSE KAPA
$0.54 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Kairos Pharma (KAPA) Cash & Equivalents (2023 - 2025)

Updated

Kairos Pharma's Cash & Equivalents was $4.49 million in Q4 2025, up 253.1% from $1.27 million a year earlier.

Analysis

Kairos Pharma (KAPA) Cash & Equivalents (2023 - 2025) Analysis & Trends

From Q3 2023 onward, Kairos Pharma has reported Cash & Equivalents for 7 quarters.

  • In earlier years, Cash & Equivalents was $1.27 million in FY2024 and $93,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 16.91 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 976.00 Mn
10 Kairos Pharma 11.24 Mn -1.17 Mn - 4.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.49 Mn
Jun 30, 2025 3.03 Mn
Mar 31, 2025 3.62 Mn
Dec 31, 2024 1.27 Mn
Sep 30, 2024 3.22 Mn
Dec 31, 2023 93,000.00
Sep 30, 2023 99,000.00
API Access

Kairos Pharma Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=KAPA&period=max&api_key=YOUR_API_KEY